This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nu Skin Enterprises (NUS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Nu Skin Enterprises (NUS) closed at $50.08, marking a +1.36% move from the previous day.
General Mills (GIS) Queued Up for Q2 Earnings: Factors to Watch
by Zacks Equity Research
General Mills' (GIS) second-quarter fiscal 2022 performance will likely reflect robust at-home food demand. However, higher input cost inflation is a concern.
Nu Skin Enterprises (NUS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Nu Skin Enterprises (NUS) closed the most recent trading day at $47.13, moving -1.09% from the previous trading session.
Why Is Nu Skin (NUS) Up 3.7% Since Last Earnings Report?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for November 30th
by Zacks Equity Research
BJRI, DLB, NUS, TXRH, and GPS have been added to the Zacks Rank #5 (Strong Sell) List on November 30, 2021.
New Strong Sell Stocks for November 18th
by Zacks Equity Research
XRX, SHOP, IBM, BLMN, and NUS have been added to the Zacks Rank #5 (Strong Sell) List on November 18, 2021.
Nu Skin (NUS) Q3 Earnings Beat Estimates, Revenues Down
by Zacks Equity Research
Nu Skin's (NUS) third-quarter 2021 earnings and revenues decline year over year on disruptions caused by the Delta variant. Also, management lowered 2021 revenue guidance.
Nu Skin Enterprises (NUS) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 12.79% and 0.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Factors to Consider as Nu Skin (NUS) Gears Up for Q3 Earnings
by Zacks Equity Research
Nu Skin's (NUS) third-quarter results are likely to reflect the impact of delta variant across various markets, though focus on enhancing sales leaders has been a driver.
Nu Skin Enterprises (NUS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Nu Skin Enterprises (NUS) closed at $40.19 in the latest trading session, marking a +1.01% move from the prior day.
Earnings Preview: Nu Skin Enterprises (NUS) Q3 Earnings Expected to Decline
by Zacks Equity Research
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin Enterprises (NUS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Nu Skin Enterprises (NUS) closed the most recent trading day at $41.07, moving -0.85% from the previous trading session.
New Strong Sell Stocks for October 18th
by Zacks Equity Research
CNFR, RACE, GGG, NUS, and LRN have been added to the Zacks Rank #5 (Strong Sell) List on October 18, 2021.
The Estee Lauder Companies (EL) Gains on Online & Skin Care Sales
by Zacks Equity Research
Strength in The Estee Lauder Companies' (EL) Skin Care portfolio is a major driver. Also, the company is implementing stringent cost-curtailment practices.
Nu Skin's (NUS) Solid Innovations Aid, Pandemic-Led Hurdles Hurt
by Zacks Equity Research
Nu Skin (NUS) is benefiting from effective product launches. However, the company is battling challenges stemming from the spread of the delta variant across several markets.
Nu Skin (NUS) Lowers Q3 Revenue View Amid Pandemic-Led Hurdles
by Zacks Equity Research
Nu Skin (NUS) expects Q3 revenues in the band of $637-$642 million, lower than the previous range. Challenges caused by the delta variant across several markets are a downside.
Zacks.com featured highlights include: Academy Sports and Outdoors, M/I Homes, MetLife, ArcelorMittal and Nu Skin Enterprises
by Zacks Equity Research
Zacks.com featured highlights include: Academy Sports and Outdoors, M/I Homes, MetLife, ArcelorMittal and Nu Skin Enterprises
Coty (COTY) Unveils Plans to Offload 9% Stake in Wella To KKR
by Zacks Equity Research
Coty (COTY) signs an agreement to offload nearly 9% stake in Wella to KKR. Through the deal, management expects to simplify Coty's capital structure.
7 Low Price-to-Sales Stocks for Value-Focused Investors
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like SIG, GIII, NUS, MET, MT, MOS and HIBB are promising picks.
Pick These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratios
by Anindya Barman
We have screened bargain stocks ASO, MHO, MET, MT and NUS based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
Inter Parfums (IPAR) Teams Up With G-III Apparel to Boost Growth
by Zacks Equity Research
Inter Parfums (IPAR) enters into a licensing agreement with G-III Apparel to create, develop as well as distribute fragrances and related items.
Coty (COTY) Teams Up With Perfect Corp. to Accelerate Growth
by Zacks Equity Research
Coty (COTY) signs a multi-channel agreement with Perfect Corp. to help customers shop in the most convenient and personalized manner both online and offline.
Zacks Value Investor Highlights: Nu Skin Enterprises, VF Corp, Yamana Gold, Meritor and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks Value Investor Highlights: Nu Skin Enterprises, VF Corp, Yamana Gold, Meritor and Vertex Pharmaceuticals
5 Top Ranked Stocks on Sale Right Now
by Tracey Ryniec
These stocks are disconnected from their earnings outlook as the analysts remain bullish but the Street is bearish.
The Estee Lauder Companies (EL) Gains on Skin Care, Online Strength
by Zacks Equity Research
The Estee Lauder Companies (EL) is implementing new technology and digital experiences to boost growth. Also, the company's Skin Care portfolio is performing well.